Breaking News Instant updates and real-time market news.

AVEO

Aveo Pharmaceuticals

$1.03

-0.5 (-32.68%)

07:03
04/04/19
04/04
07:03
04/04/19
07:03

Aveo Pharmaceuticals 21.74M share Spot Secondary priced at $1.15

H.C. Wainwright acted as sole book running manager for the offering.

  • 04

    Apr

AVEO Aveo Pharmaceuticals
$1.03

-0.5 (-32.68%)

02/04/19
02/04/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Aveo Pharmaceuticals (AVEO) downgraded to Neutral from Buy at B. Riley FBR with analyst Harshita Polishetty saying she sees a financing overhang after the FDA recommended against the filing of the company's tivozanib new drug application. 2. BHP Billiton (BHP) downgraded to Underweight from Neutral at JPMorgan while Rio Tinto (RIO) was downgraded to Neutral from Overweight at. 3. SAP (SAP) downgraded to Neutral from Buy at BofA/Merrill. 4. MacroGenics (MGNX) downgraded to Sell from Neutral at Citi with analyst Yigal Nochomovitz saying his re-examination of the prior Phase 1 data underpinning the ongoing Phase 3 SOPHIA trial has led him to revise his base case expectation to a failure for the trial. 5. Okta (OKTA) downgraded to Sector Weight from Overweight at KeyBanc with analyst Rob Owens saying that while the Street clearly anticipates meaningful upside to expectations, he believes many of the upside scenarios render shares fairly valued at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/19/19
PIPR
02/19/19
NO CHANGE
Target $3
PIPR
Overweight
Aveo Pharmaceuticals should be bought on any weakness, says Piper Jaffray
Aveo Pharmaceuticals' full Phase III Tivo-3 data for tivozanib in an oral presentation on Saturday "showed clear advantage" for progression-free survival, overall response rate and safety, but the "immature" overall survival data show a hazard ratio of 1.12, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. The analyst believes that with more patients still on tivozanib, the hazard ratio could slip below 1.0 and meet the FDA filing requirement. He recommends buying shares of Aveo on weakness and keeps an Overweight rating on the name with a $3 price target.
03/15/19
03/15/19
NO CHANGE

Baird reiterates Outperform rating on Aveo after Q4 earnings
Baird analyst Madhu Kumar reiterated an Outperform rating and $2 price target on Aveo Pharmaceuticals after the company reported its Q4 earnings report. The analyst said in a research note partially titled "Clinical Basis for TIVO-3 OS Optimism" that he continues to have relative optimism to the Street for Fotivda, and added that a Q4 of 2019 update on TIVO-3 OS was a key potential positive catalyst for the stock.
03/28/19
NATL
03/28/19
INITIATION
NATL
Sell
Aveo Pharma initiated with a Sell, $0 price target at National Securities
National Securities initiated Aveo Pharmaceuticals with a Sell and $0 price target saying recent share appreciation is "totally unwarranted." The firm's analyst expects interim and final Phase 3 overall survival data updates to fail to support a Tivozanib NDA filing.

TODAY'S FREE FLY STORIES

BC

Brunswick

$54.52

1.09 (2.04%)

06:53
04/25/19
04/25
06:53
04/25/19
06:53
Earnings
Breaking Earnings news story on Brunswick »

Brunswick backs 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

RS

Reliance Steel

$88.83

-0.52 (-0.58%)

06:52
04/25/19
04/25
06:52
04/25/19
06:52
Earnings
Reliance Steel sees Q2 EPS $2.60-$2.70, consensus $2.48 »

Management said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

PKIUF

Parkland Fuel

$0.00

(0.00%)

06:52
04/25/19
04/25
06:52
04/25/19
06:52
Initiation
Parkland Fuel initiated  »

Parkland Fuel initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BC

Brunswick

$54.52

1.09 (2.04%)

06:52
04/25/19
04/25
06:52
04/25/19
06:52
Earnings
Brunswick reports Q1 adjusted EPS 99c, consensus 98c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

RS

Reliance Steel

$88.83

-0.52 (-0.58%)

06:51
04/25/19
04/25
06:51
04/25/19
06:51
Earnings
Reliance Steel reports Q1 EPS $2.80, consensus $2.37 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

AB

AllianceBernstein

$30.05

-0.04 (-0.13%)

06:51
04/25/19
04/25
06:51
04/25/19
06:51
Earnings
AllianceBernstein reports Q1 EPS , consensus 54c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    Jun

CASY

Casey's General Stores

$133.30

0.4 (0.30%)

06:51
04/25/19
04/25
06:51
04/25/19
06:51
Initiation
Casey's General Stores initiated  »

Casey's General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NVT

nVent Electric

$28.40

0.19 (0.67%)

06:50
04/25/19
04/25
06:50
04/25/19
06:50
Earnings
nVent Electric sees Q2 adjusted EPS 42c-46c, consensus 47c »

Sees Q2 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WMT

Walmart

$103.51

0.45 (0.44%)

06:50
04/25/19
04/25
06:50
04/25/19
06:50
Periodicals
Walmart to evaluate options for Asda including IPO, Bloomberg reports »

Walmart is reviewing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    May

  • 16

    May

  • 29

    May

  • 05

    Jun

  • 07

    Jun

  • 13

    Nov

AERI

Aerie Pharmaceuticals

$38.85

-0.64 (-1.62%)

06:49
04/25/19
04/25
06:49
04/25/19
06:49
Hot Stocks
Aerie Pharmaceuticals: NDA for AR-13503 accepted by FDA »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 23

    May

LLY

Eli Lilly

$117.99

0.48 (0.41%)

06:49
04/25/19
04/25
06:49
04/25/19
06:49
Hot Stocks
Eli Lilly facilitating withdrawal of Lartruvo after ANNOUNCE trial failure »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

NVT

nVent Electric

$28.40

0.19 (0.67%)

06:49
04/25/19
04/25
06:49
04/25/19
06:49
Earnings
nVent Electric still sees 2019 adjusted EPS $1.80-$1.90, consensus $1.87 »

Still sees 2019 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

FAF

First American

$56.18

0.17 (0.30%)

06:48
04/25/19
04/25
06:48
04/25/19
06:48
Earnings
First American reports Q1 EPS 74c, consensus 68c »

Reports Q1 revenue $1.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

  • 13

    Nov

NVT

nVent Electric

$28.40

0.19 (0.67%)

06:47
04/25/19
04/25
06:47
04/25/19
06:47
Earnings
nVent Electric reports Q1 adjusted EPS 39c , consensus 39c »

Reports Q1 revenue $538M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ENB

Enbridge

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Downgrade
Enbridge rating change  »

Enbridge downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

GBNXF

Gibson Energy

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Downgrade
Gibson Energy rating change  »

Gibson Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAD

Lithia Motors

$104.90

7.19 (7.36%)

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Upgrade
Lithia Motors rating change at Stephens »

Stephens upgrades Lithia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    May

  • 13

    Nov

BBU

Brookfield Business Partners

$37.80

-0.17 (-0.45%)

06:45
04/25/19
04/25
06:45
04/25/19
06:45
Hot Stocks
Brookfield Business Partners selling BGRS for $230M in proceeds »

Brookfield Business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

CBZ

CBIZ

$20.59

-0.005 (-0.02%)

06:44
04/25/19
04/25
06:44
04/25/19
06:44
Earnings
CBIZ backs FY19 EPS view up 10%-12%, consensus $1.20 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 06

    Aug

NGD

New Gold

$0.88

0.0253 (2.96%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Earnings
New Gold reports Q1 adjusted EPS 0c, consensus 1c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

MTSI

Macom

$15.86

-0.33 (-2.04%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Downgrade
Macom rating change  »

Macom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

CBZ

CBIZ

$20.59

-0.005 (-0.02%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Earnings
CBIZ reports Q1 EPS 67c, consensus 70c »

Reports Q1 revenue $270M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 06

    Aug

BIP

Brookfield Infrastructure

$41.62

-0.03 (-0.07%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Downgrade
Brookfield Infrastructure rating change  »

Brookfield Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

WYNN

Wynn Resorts

$144.35

1.35 (0.94%)

06:42
04/25/19
04/25
06:42
04/25/19
06:42
Upgrade
Wynn Resorts rating change  »

Wynn Resorts upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ALXN

Alexion

$130.12

-2.24 (-1.69%)

06:41
04/25/19
04/25
06:41
04/25/19
06:41
Earnings
Alexion raises FY19 adj. EPS view to $9.25-$9.45 from $9.10-$9.30 »

FY19 consensus $9.31.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

  • 06

    May

  • 14

    May

  • 28

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.